Advertisement
NONOF vs NVO
To understand the difference between Novo Nordisk - Ordinary Shares - Class B (NONOF) vs. Novo Nordisk - ADR (NVO) it is enough to know the definitions of Ordinary Shares - Class B and ADR
Ordinary Shares - Class B - Generally, Class B shares are issued by a company as a common stock with fewer voting rights and lower dividend priority than Class A shares. Class B may also have lower repayment priority in the event of a bankruptcy.
ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
NONOF’s FA Score shows that 2 FA rating(s) are green whileNVO’s FA Score has 2 green FA rating(s).
- NONOF’s FA Score: 2 green, 3 red.
- NVO’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NONOF’s TA Score shows that 5 TA indicator(s) are bullish while NVO’s TA Score has 5 bullish TA indicator(s).
- NONOF’s TA Score: 5 bullish, 4 bearish.
- NVO’s TA Score: 5 bullish, 4 bearish.
Price Growth
NONOF (@Pharmaceuticals: Major) experienced а +1.50% price change this week, while NVO (@Pharmaceuticals: Major) price change was +2.60% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.79%. For the same industry, the average monthly price growth was +6.10%, and the average quarterly price growth was +13.36%.
Reported Earning Dates
NVO is expected to report earnings on Nov 05, 2025.
Industries' Descriptions
@Pharmaceuticals: Major (+2.79% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
| NONOF | NVO | NONOF / NVO | |
| Capitalization | 226B | 226B | 100% |
| EBITDA | 147B | 147B | 100% |
| Gain YTD | -40.394 | -38.090 | 106% |
| P/E Ratio | 13.08 | 13.38 | 98% |
| Revenue | 303B | 303B | 100% |
| Total Cash | 41.6B | 41.6B | 100% |
| Total Debt | 119B | 119B | 100% |
NONOF | NVO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 1 | 59 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 13 Undervalued | 15 Undervalued | |
PROFIT vs RISK RATING 1..100 | 85 | 81 | |
SMR RATING 1..100 | 14 | 14 | |
PRICE GROWTH RATING 1..100 | 92 | 92 | |
P/E GROWTH RATING 1..100 | 98 | 98 | |
SEASONALITY SCORE 1..100 | n/a | 4 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NONOF's Valuation (13) in the null industry is in the same range as NVO (15) in the Pharmaceuticals Major industry. This means that NONOF’s stock grew similarly to NVO’s over the last 12 months.
NVO's Profit vs Risk Rating (81) in the Pharmaceuticals Major industry is in the same range as NONOF (85) in the null industry. This means that NVO’s stock grew similarly to NONOF’s over the last 12 months.
NVO's SMR Rating (14) in the Pharmaceuticals Major industry is in the same range as NONOF (14) in the null industry. This means that NVO’s stock grew similarly to NONOF’s over the last 12 months.
NVO's Price Growth Rating (92) in the Pharmaceuticals Major industry is in the same range as NONOF (92) in the null industry. This means that NVO’s stock grew similarly to NONOF’s over the last 12 months.
NVO's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as NONOF (98) in the null industry. This means that NVO’s stock grew similarly to NONOF’s over the last 12 months.
| NONOF | NVO | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 90% | 1 day ago 81% |
| Stochastic ODDS (%) | 1 day ago 61% | 1 day ago 61% |
| Momentum ODDS (%) | 1 day ago 80% | 1 day ago 73% |
| MACD ODDS (%) | 1 day ago 77% | 1 day ago 57% |
| TrendWeek ODDS (%) | 1 day ago 76% | 1 day ago 67% |
| TrendMonth ODDS (%) | 1 day ago 73% | 1 day ago 62% |
| Advances ODDS (%) | 1 day ago 76% | 1 day ago 67% |
| Declines ODDS (%) | 10 days ago 62% | 4 days ago 58% |
| BollingerBands ODDS (%) | 1 day ago 79% | 1 day ago 69% |
| Aroon ODDS (%) | 1 day ago 78% | 1 day ago 58% |
Advertisement